Agilon Health (AGL) Liabilities and Shareholders Equity (2020 - 2026)

Agilon Health has reported Liabilities and Shareholders Equity for 7 years, with the latest figure at $1.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 22.14% year-over-year to $1.5 billion; the trailing twelve-month figure through Mar 2026 stood at $6.1 billion (down 23.18% YoY), and the FY2025 full-year result was $1.3 billion, down 26.68% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $1.5 billion, up from $1.3 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $2.4 billion in Q2 2023, with the low at $1.3 billion in Q4 2025.
• Historically, Liabilities and Shareholders Equity has averaged $1.9 billion across 5 years, with a median of $1.9 billion in 2022.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity surged 223.19% — and 2025, when it retreated 26.68%.
• Agilon Health's Liabilities and Shareholders Equity stood at $1.7 billion in 2022, then grew by 2.56% to $1.7 billion in 2023, then dropped by 0.4% to $1.7 billion in 2024, then slipped by 26.68% to $1.3 billion in 2025, then gained by 18.38% to $1.5 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $1.5 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.